SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-282451
Filing Date
2021-09-24
Accepted
2021-09-24 16:59:06
Documents
15
Period of Report
2021-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d151012d8k.htm   iXBRL 8-K 28491
2 EX-10.1 d151012dex101.htm EX-10.1 53547
3 EX-10.2 d151012dex102.htm EX-10.2 53494
4 EX-10.3 d151012dex103.htm EX-10.3 54615
  Complete submission text file 0001193125-21-282451.txt   362681

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20210922.xsd EX-101.SCH 2937
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20210922_lab.xml EX-101.LAB 18123
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20210922_pre.xml EX-101.PRE 11435
8 EXTRACTED XBRL INSTANCE DOCUMENT d151012d8k_htm.xml XML 3414
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 211278023
SIC: 2836 Biological Products, (No Diagnostic Substances)